Puma Biotechnology Inc
NASDAQ:PBYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
Energy Transfer LP
NYSE:ET
|
US |
|
D
|
De' Longhi SpA
XBER:DLN
|
IT |
|
Adient PLC
F:18I
|
IE |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
Nordson Corp
NASDAQ:NDSN
|
US |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Loomis AB
STO:LOOMIS
|
SE |
|
D
|
Deere & Co
F:DCO
|
US |
|
Companhia de Saneamento Basico do Estado de Sao Paulo SABESP
BOVESPA:SBSP3
|
BR |
|
R
|
Royal Bank of Canada
SWB:RYC
|
CA |
|
A
|
Arcosa Inc
SWB:EOB
|
US |
Wall St Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBYI's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Puma Biotechnology Inc?
Projected CAGR
-1%
The compound annual growth rate for Revenue over the next 5 years is -1%.
What is the Gross Profit forecast for Puma Biotechnology Inc?
Projected CAGR
-1%
The compound annual growth rate for Gross Profit over the next 5 years is -1%.
What is the Pre-Tax Income forecast for Puma Biotechnology Inc?
Projected CAGR
-42%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -42%.
What is the Net Income forecast for Puma Biotechnology Inc?
Projected CAGR
-25%
The compound annual growth rate for Net Income over the next 5 years is -25%.
